Another hypothesis: Oxford was originally going to partner with Merck [1] but there were no supply guarantees in that contract. AstraZeneca was willing to give guarantees and run production in the UK, so the UK government leaned on Oxford and had them partner with the more agreeable supplier.

[1] https://news.sky.com/story/covid-19-rejected-contracts-and-a...